These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24385081)

  • 1. Role of viability imaging in the post-STICH era.
    Shah BN; Senior R
    Curr Opin Cardiol; 2014 Mar; 29(2):145-51. PubMed ID: 24385081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era.
    Shah BN; Khattar RS; Senior R
    Eur Heart J; 2013 May; 34(18):1323-36. PubMed ID: 23420867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viability by MRI or PET would not have changed the results of the STICH trial.
    Asrani NS; Chareonthaitawee P; Pellikka PA
    Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability by MRI or PET would have changed the results of the STICH trial.
    Srichai MB; Jaber WA
    Prog Cardiovasc Dis; 2013; 55(5):487-93. PubMed ID: 23518377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The world post-STICH: is this a "Game Changer?" A non-invasive cardiologist's perspective-revascularization is the treatment of choice only in patients who fail medical therapy.
    Elamm C; Fang JC
    Prog Cardiovasc Dis; 2013; 55(5):466-9. PubMed ID: 23518373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of revascularization in chronic heart failure.
    Gurunathan S; Ahmed A; Senior R
    Curr Heart Fail Rep; 2015 Apr; 12(2):112-9. PubMed ID: 25500783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revascularization in severe left ventricular dysfunction: the role of viability testing.
    Chareonthaitawee P; Gersh BJ; Araoz PA; Gibbons RJ
    J Am Coll Cardiol; 2005 Aug; 46(4):567-74. PubMed ID: 16098417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revascularization for ischaemic cardiomyopathy.
    Shanmugam G; Légaré JF
    Curr Opin Cardiol; 2008 Mar; 23(2):148-52. PubMed ID: 18303528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Treatment for Ischemic Heart Failure (STICH) trial: A review of outcomes.
    Hassanabad AF; MacQueen KT; Ali I
    J Card Surg; 2019 Oct; 34(10):1075-1082. PubMed ID: 31374589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The world post STICH: is this a "Game Changer?" A surgeon's perspective--revascularization is still the treatment of choice.
    Daggubati R; Arumugham P; Ferguson TB
    Prog Cardiovasc Dis; 2013; 55(5):470-5. PubMed ID: 23518374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization in heart failure in the post-STICH era.
    Jha S; Flamm SD; Kwon DH
    Curr Heart Fail Rep; 2013 Dec; 10(4):365-72. PubMed ID: 24142670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Revascularization for Ischemic Cardiomyopathy in the Post-STICH Era.
    Khera S; Panza JA
    Cardiol Rev; 2015; 23(4):153-60. PubMed ID: 25715329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical ventricular restoration procedure: single-center comparison of Surgical Treatment of Ischemic Heart Failure (STICH) versus non-STICH patients.
    Goh S; Prior D; Newcomb A; McLellan A; Mack J; Callaghan S; Dimitriou J; Rosalion A; Nixon I; Yii M
    Ann Thorac Surg; 2013 Feb; 95(2):506-12. PubMed ID: 23245443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Revascularization of the hibernated myocardium: a clinical problem still unsolved].
    Ammirati E; Guida V; Rimoldi OE; Camici PG
    G Ital Cardiol (Rome); 2012 Feb; 13(2):102-9. PubMed ID: 22322550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolving Paradigm of Revascularization in Ischemic Cardiomyopathy: from Recovery of Systolic Function to Protection Against Future Ischemic Events.
    Isath A; Panza JA
    Curr Cardiol Rep; 2023 Nov; 25(11):1513-1521. PubMed ID: 37874470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy.
    Isomura T; Hoshino J; Fukada Y; Kitamura A; Katahira S; Kondo T; Iwasaki T; Buckberg G;
    Eur J Heart Fail; 2011 Apr; 13(4):423-31. PubMed ID: 21317149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.